Loading clinical trials...

A Study to Compare Analyte Levels in Blood Samples Collected Using the TAP20-C Device With Results Obtained by Fingerstick | Clinical Trials | Clareo Health

UNKNOWNNA

A Study to Compare Analyte Levels in Blood Samples Collected Using the TAP20-C Device With Results Obtained by Fingerstick

NCT02045758•Seventh Sense Biosystems

View on ClinicalTrials.gov

Summary

This study will compare blood collection from the forearm using an investigational device TAP20-C to blood collection from the fingertip.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Healthy Subject Group
•1. Male and female volunteers 18 years of age or older.
•2. Voluntary written consent to participate in this study. Diabetic Subject Group
•
•1. Male and female volunteers 18 years of age or older.
•2. Have been diagnosed with Type 1 or Type 2 diabetes mellitus by self-report.
•3. Voluntary written consent to participate in this study.

Exclusion Criteria

•1. Subjects who are pregnant or nursing mothers by self-report.
•2. Subjects with a history of skin disorders or who present with abnormal skin integrity or atypical skin health within the areas to be tested.
•3. Subjects with a missing index or middle finger on either hand or a missing forearm
•4. Subjects who have known allergies to titanium.

Locations (1)

Seventh Sense Biosystems

Cambridge, Massachusetts, United States

Key Dates

Start Date

December 1, 2014

Primary Completion Date

June 1, 2015

Completion Date

September 1, 2015

Last Updated

September 3, 2014

Enrollment

120

ESTIMATED participants

Conditions

Diabetes

Interventions

Fingerstick

DEVICE

TAP20-C

DEVICE

Contacts

Howard Bernstein, MD, Phd

CONTACT

617-547-7246 hbernstein@7sbio.com

Genetic Studies of Insulin and Diabetes

NCT00001987

Diabetes MellitusSevere Insulin Resistance

View study

RECRUITINGNA

Feasibility of a Tailored Online Self-compassion Intervention

NCT07051005

Type 1 Diabetes MellitusType 2 Diabetes Mellitus (T2DM)

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 3, 2014Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Study to Compare Analyte Levels in Blood Samples Collected Using the TAP20-C Device With Results Obtained by Fingerstick

Inclusion Criteria

Exclusion Criteria

Genetic Studies of Insulin and Diabetes

Feasibility of a Tailored Online Self-compassion Intervention

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction

Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes